Clinical and biochemical aspirin resistance in patients with recurrent cerebral ischemia

Clinical Neurology and Neurosurgery

Volumn 115, Issue 7, 2013, Pages 944-947

  El Mitwalli, Ashraf ^a   Azzam, Hanan ^a   Abu Hegazy, Mohammad ^a   Gomaa, Mohamed ^a   Wasel, Yasser ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Aspirin; Ischemic stroke; Recurrent; Resistance

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; PYROPHOSPHATE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; DEMOGRAPHY; DISEASE SEVERITY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; LABORATORY TEST; LACUNAR STROKE; LIGHT TRANSMITTANCE AGGREGOMETRY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; RADIODIAGNOSIS; RECURRENT DISEASE; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; AGED; ARACHIDONIC ACID; ASPIRIN; BRAIN ISCHEMIA; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; SPECIMEN HANDLING; TREATMENT FAILURE;

EID: 84878868302     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2012.09.025     Document Type: Article

References (34)

1. R.L. Sacco, E.J. Benjamin, J.P. Broderick, M. Dyken, J.D. Easton, and W.M. Feinberg American Heart Association Prevention Conference. IV: prevention and rehabilitation of stroke: risk factors Stroke 28 1997 1507 1517
2. J. Burn, M. Dennis, and J. Bamford Long-term risk of recurrent stroke after a first ever stroke. The Oxfordshire Community Stroke Project Stroke 25 1994 333 337
3. K. Hardie, G.J. Hankey, K. Jamrozik, R.J. Broadhurst, and C. Anderson Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study Stroke 35 2004 731 735
4. K.M. Mohan, S.L. Crichton, A.P. Grieve, A.G. Rudd, C.D. Wolfe, and P.U. Heuschmann Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register Journal of Neurology, Neurosurgery and Psychiatry 80 9 2009 1012 1018
5. B.M. Coull, L.S. Williams, L.B. Goldstein, J.F. Meschia, D. Heitzman, and S. Chaturvedi Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association) Stroke 33 2002 1934 1942
6. International Stroke Trial Collaborative Group The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke Lancet 349 1997 1569 1581
7. Copernicus: The Marketing Investment Strategy Group Patient flow analysis of stroke/TIA patients 2006 Copernicus Waltham, Mass http://onlinelibrary. wiley.com/doi/10.1111/j.1742-1241.2007.01515.x/?url-ver=Z39.88-2004&rft-val- fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.btitle= Patient Flow Analysis of Stroke%2FTIA Patients&rft.date=2006&rfr-id=inf
8. A.B. Maulaz, D.C. Bezerra, P. Michel, and J. Bogousslavsky Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke Archives of Neurology 62 8 2005 1217 1220
9. I. Sibon, and J.M. Orgogozo Antiplatelet drug discontinuation is a risk factor for ischemic stroke Neurology 62 2004 1187 1189
10. C. Patrono Aspirin resistance: definition, mechanisms and clinical read-outs Journal of Thrombosis and Haemostasis 1 2003 1173 1710
11. J. Dawson, T. Quinn, M. Rafferty, P. Higgins, G. Ray, and K.R. Lees Aspirin resistance and compliance with therapy Cardiovascular Therapeutics 29 5 2011 301 307
12. M. Postuła, B. Tarchalska-Kryńska, K.J. Filipiak, D. Kosior, A. Serafin, and Z. Huczek Factors responsible for "aspirin resistance"-can we identify them? Kardiologia Polska 68 4 2010 403 411 [discussion 412-413]
13. V.A. Pujol Lereis, S. Ameriso, G.P. Povedano, and Ameriso SF Ischemic stroke in patients receiving aspirin Journal of Stroke and Cerebrovascular Diseases June 2011 [Epub ahead of print, PubMed PMID: 21703876]
14. H.P. Adams, B.H. Benedixen, L.J. Kappelle, J. Biller, B.B. Love, and D.L. Gordon Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial Stroke 24 1993 35 41
15. J.H.W. Pexman, P.A. Barber, M.D. Hilla, R.J. Sevick, A.M. Demchuk, and M.E. Hudon Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scan in patients with acute stroke American Journal of Neuroradiology 22 2001 1534 1542
16. G.V. Born Aggregation of blood platelets by adenosine diphosphate and its reversal Nature 194 1962 927 929
17. A.A. Weber, B. Przytulski, A. Schanz, T. Hohlfeld, and K. Schror Towards a definition of aspirin resistance: a typological approach Platelets 13 2002 37 40
18. C. Patrono, B. Coller, G.A. FitzGerald, J. Hirsh, and G. Roth Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the seventh ACCP conference on antithrombotic and thrombolytic therapy Chest 126 Suppl. 3 2004 64S 234S
19. F. Catella-Lawson, M.P. Reilly, S.C. Kapoor, A.J. Cucchiara, S. DeMarco, and B. Tournier Cyclooxygenase inhibitors and the antiplatelet effects of aspirin New England Journal of Medicine 345 2001 1809 1817
20. P.A. Gum, K. Kottke-Marchant, E.D. Poggio, H. Gurm, P.A. Welsh, and L. Brooks Profile and prevalence of aspirin resistance in patients with cardiovascular disease American Journal of Cardiology 88 2001 230 235
21. C.M. Helgason, K.L. Tortorice, S.R. Winkler, D.W. Penney, J.J. Schuler, and T.J. McClelland Aspirin response and failure in cerebral infarction Stroke 24 1993 345 350
22. J.M. Pappas, J.C. Westengard, and B.S. Bull Population variability in the effect of aspirin on platelet function. Implications for clinical trials and therapy Archives of Pathology and Laboratory Medicine 118 1994 801 804
23. K.H. Grotemeyer Effects of acetylsalicylic acid in stroke patients. Evidence of nonresponders in a subpopulation of treated patients Thrombosis Research 63 1991 587 593
24. J. Valles, M.T. Santos, J. Aznar, A. Osa, A. Lago, and J. Cosin Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity Circulation 97 1998 350 355
25. A.D. Michelson Platelet function testing in cardiovascular diseases [online exclusive article] Circulation 110 2004 e489 e493
26. M. Zytkiewicz, L. Giełwanowska, E. Wojtasińska, P. Psuja, and K. Zawilska Resistance to acetylsalicylic acid in patients after ischemic stroke Polskie Archiwum Medycyny Wewnȩtrznej 118 12 2008 727 733
27. U.S. Tantry, K.P. Bliden, and P.A. Gurbel Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation Journal of the American College of Cardiology 46 9 2005 1705 1709
28. P.A. Sadiq, A. Puri, M. Dixit, A. Ghatak, S.K. Dwivedi, and V.S. Narain Profile and prevalence of aspirin resistance in Indian patients with coronary artery disease Indian Heart Journal 57 6 2005 658 661
29. R. Fitzgerald, and M. Pirmohamed Aspirin resistance: effect of clinical, biochemical and genetic factors Pharmacology & Therapeutics 130 2 2011 213 225
30. J. Hung, J.Y. Lam, L. Lacoste, and G. Letchacovski Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin Circulation 92 1995 2432 2436
31. M. Friend, I. Vucenik, and M. Miller Research pointers: platelet responsiveness to aspirin in patients with hyperlipidaemia British Medical Journal 326 2003 82 83
32. N.A. Englyst, G. Horsfield, J. Kwan, and C.D. Byrne Aspirin resistance is more common in lacunar strokes than embolic strokes and is related to stroke severity Journal of Cerebral Blood Flow and Metabolism 28 6 2008 1196 1203
33. F. Violi, and P. Pignatelli Aspirin resistance: is this term meaningful? Current Opinion in Hematology 13 5 2006 331 336
34. Y. Ito, T. Mitsufuji, F. Yamamoto, Y. Hashimoto, T. Hirano, and M. Uchino Non-taking oral antithrombotic agents in patients with ischemic stroke Rinsho Shinkeigaku. Clinical Neurology 51 1 2011 35 37 [abstract; full article in Japanese]